Resources

Coulter Partners successfully completed a search assignment for Biomia and is pleased to announce the placement of Frederick Westhorpe, PhD as Chief Scientific Officer (CSO).

NHS 10 Year Health Plan for England, a strategy for European Life Sciences and hope to see you at the “sunny” BIA Summer Party on Wednesday.

Coulter Partners successfully completed search assignments for Augustine Therapeutics NV.

Cancer Research Horizons, the innovation arm of Cancer Research UK, has appointed its first Clinical Advisory Board to provide strategic guidance on the development of novel cancer therapeutics emerging from its drug discovery division, Therapeutic Innovation.

Discovery Park opened its doors for the East Kent Science Jamboree, hosting a record-breaking 1,500 children from 51 Kent schools for a two-day science spectacular.

Aravax announced the appointment of Dr Adrian Parry as Director of CMC (Chemistry, Manufacturing and Controls), based at the Company’s Oxford, UK site.

Present Made, Eddington, is leading the way with Cambridge’s first purpose-built, large-scale corporate letting scheme – a pioneering development that brings 21st-century executive living to one of the UK’s most dynamic science and technology hubs.

In this Q&A blog, BIA spoke to Natasha Gray, Associate & Life Sciences Advisory Service Lead at Warn, a new BIA member.

UK life sciences take centre stage at BIO following a promising Spending Review.

A new residential development in North Cambridge is offering science and technology businesses a ready-made solution to one of the city’s most pressing challenges: housing professional staff within easy reach of major employment hubs.

From a multi-billion-pound boost to R&D and life sciences manufacturing, to scaling innovative businesses through the British Business Bank, the Review signals significant investment.

Steve Bates OBE, CEO of the UK BioIndustry Association, responded to the government's Spending Review.

Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that Dr Robert Tansley is appointed Chief Medical Officer with immediate effect.

Discovery Park has launched applications for its immersive business growth programme, ‘Discovery Spark’, seeking early-stage companies in cardiovascular and cardiometabolic health.

PIR International spoke with experienced life science executive, Bob Radie, as part of there BioLeader interview series.

In this blog, Albert Maguire-King, Media and Communications Executive at the BIA, shares his insights on BIA's recent Start-up Festival.

An experienced clinician scientist and surgery consultant, Dr Gianmarco Contino brings deep expertise in gastrointestinal cancers and cancer genomics.

In this blog, Kate Barclay, Skills Consultant at BIA, introduces Skills England, a new Executive Agency within the Department for Education.

Coulter Partners successfully completed a search assignment for Melt&Marble and is pleased to announce the placement of Tue Hodal as its first Chief Technology Officer (CTO).

At BIA’s recent Start-up festival, we caught up with Mark Bartlett, CEO of StoreGene, to learn more about his journey, what drives him, and his advice for founders navigating the world of genomics and startups.